These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 30779070

  • 1. LncRNA 00152 promotes the development of hepatocellular carcinoma by activating JAK2/STAT3 pathway.
    Li SJ, Sui MH, Sun ZX, Zhang WW.
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1038-1046. PubMed ID: 30779070
    [Abstract] [Full Text] [Related]

  • 2. Long Noncoding RNA HOST2 Promotes Epithelial-Mesenchymal Transition, Proliferation, Invasion and Migration of Hepatocellular Carcinoma Cells by Activating the JAK2-STAT3 Signaling Pathway.
    Wu Y, Yuan T, Wang WW, Ge PL, Gao ZQ, Zhang G, Tang Z, Dang XW, Zhao YF, Zhang JY, Jiang GZ.
    Cell Physiol Biochem; 2018 Feb; 51(1):301-314. PubMed ID: 30453302
    [Abstract] [Full Text] [Related]

  • 3. Long non-coding RNA FEZF1-AS1 promotes cell invasion and epithelial-mesenchymal transition through JAK2/STAT3 signaling pathway in human hepatocellular carcinoma.
    Wang YD, Sun XJ, Yin JJ, Yin M, Wang W, Nie ZQ, Xu J.
    Biomed Pharmacother; 2018 Oct; 106():134-141. PubMed ID: 29957463
    [Abstract] [Full Text] [Related]

  • 4. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L, Han T, Liu K, Lei CG, Wang ZC, Shi GJ.
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [Abstract] [Full Text] [Related]

  • 5. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375.
    Li L, Xiao C, He K, Xiang G.
    IUBMB Life; 2021 Sep; 73(9):1153-1165. PubMed ID: 34148288
    [Abstract] [Full Text] [Related]

  • 6. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J, Kong Y, Gao Z, Liu Y, Zhu P, Yu Z.
    Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
    [Abstract] [Full Text] [Related]

  • 7. NLRC3 silencing accelerates the invasion of hepatocellular carcinoma cell via IL-6/JAK2/STAT3 pathway activation.
    Kang JH, Li MJ, Luan PP, Jiang DK, Chen YW, Xu X, Yu Q, Xu YW, Su Q, Peng WH, Jian WX.
    Cell Biol Int; 2020 Oct; 44(10):2053-2064. PubMed ID: 32584509
    [Abstract] [Full Text] [Related]

  • 8. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z, Song J, Tang B, Fang S, Zhang D, Zheng L, Wu F, Gao Y, Chen C, Hu X, Weng Q, Yang Y, Tu J, Ji J.
    J Exp Clin Cancer Res; 2020 Nov 25; 39(1):259. PubMed ID: 33234142
    [Abstract] [Full Text] [Related]

  • 9. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J, Xu X, Wu S, Shi W, Zhang G, Cao Y, Wang Z, Wu J, Jiang C.
    Cancer Med; 2023 Sep 25; 12(17):18078-18097. PubMed ID: 37563971
    [Abstract] [Full Text] [Related]

  • 10. miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer.
    Zhang CS, Lin Y, Sun FB, Gao J, Han B, Li SJ.
    Eur Rev Med Pharmacol Sci; 2019 Jan 25; 23(1):146-154. PubMed ID: 30657556
    [Abstract] [Full Text] [Related]

  • 11. DC-SIGN mediates gastric cancer progression by regulating the JAK2/STAT3 signaling pathway and affecting LncRNA RP11-181G12.2 expression.
    Li X, Na H, Xu L, Zhang X, Feng Z, Zhou X, Cui J, Zhang J, Lin F, Yang S, Yue F, Mousa H, Zuo Y.
    Biomed Pharmacother; 2020 Jan 25; 121():109644. PubMed ID: 31766099
    [Abstract] [Full Text] [Related]

  • 12. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X, Hu ZP, Li Z, Gao PJ, Zhu JY.
    World J Gastroenterol; 2015 Jul 28; 21(28):8588-604. PubMed ID: 26229401
    [Abstract] [Full Text] [Related]

  • 13. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X, Gao Y, Qin J, Lu S.
    Am J Physiol Gastrointest Liver Physiol; 2018 May 01; 314(5):G559-G565. PubMed ID: 29097358
    [Abstract] [Full Text] [Related]

  • 14. LncRNA HOTAIRM1 inhibits the progression of hepatocellular carcinoma by inhibiting the Wnt signaling pathway.
    Zhang Y, Mi L, Xuan Y, Gao C, Wang YH, Ming HX, Liu J.
    Eur Rev Med Pharmacol Sci; 2018 Aug 01; 22(15):4861-4868. PubMed ID: 30070317
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR, Fang D, Di MP, Guan JL, Wang G, Liu L, Sheng JQ, Tian DA, Li PY.
    Int J Med Sci; 2020 Aug 01; 17(9):1224-1234. PubMed ID: 32547318
    [Abstract] [Full Text] [Related]

  • 16. A Novel lncRNA lncRNA-4045 Promotes the Progression of Hepatocellular Carcinoma by Affecting the Expression of AKR1B10.
    Tan C, Zeng X, Guo X, Mo M, Ma X, Liu B, Liu S, Zeng X, Huang D, Qiu X.
    Dig Dis Sci; 2024 Jul 01; 69(7):2502-2521. PubMed ID: 38662158
    [Abstract] [Full Text] [Related]

  • 17. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M, Zhang XY, Yu X.
    Biomed Pharmacother; 2017 Jan 19; 85():348-354. PubMed ID: 27899259
    [Abstract] [Full Text] [Related]

  • 19. lncRNA TUG1 regulates angiogenesis via the miR‑204‑5p/JAK2/STAT3 axis in hepatoblastoma.
    Yuan MX, Ji CY, Gao HQ, Sheng XY, Xie WX, Yin Q.
    Mol Med Rep; 2021 Aug 19; 24(2):. PubMed ID: 34080023
    [Abstract] [Full Text] [Related]

  • 20. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL, Cao SW, Ou QS, Yang B, Zheng SH, Tang J, Chen J, Hu YW, Zheng L, Wang Q.
    Mol Cancer; 2018 May 26; 17(1):93. PubMed ID: 29803224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.